Simba Gill is President & CEO of Evelo Biosciences, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Serina Therapeutics, Inc.
17 Apr 24
3
Serina Therapeutics, Inc.
17 Apr 24
4
Evelo Biosciences, Inc.
8 Nov 23
4
Evelo Biosciences, Inc.
29 Sep 23
4
Evelo Biosciences, Inc.
9 Aug 23
4
Foghorn Therapeutics Inc.
22 Jun 23
4
Evelo Biosciences, Inc.
12 Jun 23
4
Evelo Biosciences, Inc.
10 May 23
4/A
Evelo Biosciences, Inc.
10 May 23
4
Evelo Biosciences, Inc.
9 May 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | SER Serina Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 11.01 | 295,300 | 3.25 mm | 295,300 |
8 Nov 23 | EVLO Evelo Biosciences | Common Stock | Sell | Dispose S | No | Yes | 0.33 | 172 | 56.76 | 17,758 |
7 Nov 23 | EVLO Evelo Biosciences | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,172 | 0.00 | 17,930 |
7 Nov 23 | EVLO Evelo Biosciences | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,172 | 0.00 | 15,236 |
28 Sep 23 | EVLO Evelo Biosciences | Common Stock | Sell | Dispose S | No | Yes | 3.94 | 1,996 | 7.86 k | 16,758 |
27 Sep 23 | EVLO Evelo Biosciences | Common Stock | Option exercise | Acquire M | No | No | 0 | 15,000 | 0.00 | 18,754 |
27 Sep 23 | EVLO Evelo Biosciences | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 15,000 | 0.00 | 45,000 |
27 Sep 23 | EVLO Evelo Biosciences | RSU Common Stock | Grant | Acquire A | No | No | 0 | 60,000 | 0.00 | 60,000 |
8 Aug 23 | EVLO Evelo Biosciences | Common Stock | Sell | Dispose S | No | Yes | 9.51 | 342 | 3.25 k | 3,754 |
7 Aug 23 | EVLO Evelo Biosciences | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,171 | 0.00 | 4,096 |